advertisement

---

Expert Opinion on Drug Safety 7

Showing records 1 to 7 | Display all abstracts in Expert Opinion on Drug Safety

118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Zhang W
Expert Opinion on Drug Safety 2024; 23: 617-625

---

118514 Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)
Xiong X
Expert Opinion on Drug Safety 2024; 0: 1-6

---

118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Chen M
Expert Opinion on Drug Safety 2024; 23: 617-625

---

118514 Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)
Zhang X; Li X
Expert Opinion on Drug Safety 2024; 0: 1-6

---

118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Cai X; Zhang M
Expert Opinion on Drug Safety 2024; 23: 617-625

---

118514 Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)
Huang T
Expert Opinion on Drug Safety 2024; 0: 1-6

---

118901 Detection and analysis of signals of adverse events of memantine based on the US food and drug administration adverse event reporting system
Hu M; Hu Y; Yang Y; Zhu J; Du Y; Yang C
Expert Opinion on Drug Safety 2024; 23: 617-625

---